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PERCUTANEOUS PENETRATION OF STEROIDS IN MANE
ROBERT J. FELDMANN, M.D. AND HOWARD I. MAIBACH, M.D.
We previously reported quantitative data on
the percutaneous penetration of hydrocorti-
sone in man (1, 2). These observations are
extended to 14 additional steroids to obtain a
more complete view of the penetration char-
aeteristies of this class of compounds.
METHODs
General. The kinetics of percutaneous absorp-
tion may be determined from measurements of
elimination from the body, where the excretion
kinetics of the systemically administered test com-
pound are known. This subject has been reviewed
by Wurster (3). If the body excretes a compound
more rapidly than it penetrates the skin, the rate
at which the material appears in the urine will
be the rate it penetrates the skin. Total penetra-
tion may be measured even when this is not true.
The metabolites of the hormones reported here
are significantly excreted in the urine. Most of the
remainder is excreted by the liver and appears in
the stools. As rate data are difficult to obtain from
stool analysis, we have assumed that the propor-
tion between renal and hepatie excretion remains
the same throughout the experiment, correcting the
values obtained from the urine to calculate total
excretion.
Carbon'4 tracer doses were used allowing the
study of compounds for which chemical methods
of measuring total urinary metabolites are un-
known or insufficiently sensitive. Even endogenous
secretion of these hormones will not interfere with
values obtained with isotopic tracers. Fluocinolone
acetonide was labeled in the aeetonide because '4C
ring labeled material is not available. In general
labels on ester groups are not satisfactory as tracers
because the body hydrolyzes them. We tested this
possibihty by parenteral administration of fiuo-
cinolone aeetonide labeled first with "C in the
acetonide and then by 'H ring labeled compound(4). As excretion was almost the same in both
instances, the aeetonide is largely retained on the
ring and is therefore a satisfactory tracer. All other
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steroids tested including the esters were ring la-
beled at the four position.
Our analytical method involves only measuring
"C in the urine ahquot, and was identical for all
compounds.
Excretion kinetics. One microcurie of the steroid
was dissolved in 5 to 20 ml of saline using up to
10% ethanol to increase solubility, and injected
intravenously. Two or more subjects were used for
each steroid. All urine was collected for five days
divided into suitable time periods. The amount of
"C excreted divided by the duration for each time
period expressed as percent of the dose admin-
istered was plotted on semilog paper. The velocity
constant is expressed in this paper as the half-life
obtained from the plotted values.
Topieol opplieotion. The test steroid was applied
in acetone solution at 4 pg/cm'. The standard
method used was the steroid dissolved in acetone
and applied to a 13 cm' circular area demarcated
by petrolatum on the ventral forearm. Petrolatum
is not dissolved by acetone. The acetone was evap-
orated during application by blowing and was
present less than 15 seconds. This application
method comes as close as possible, consistent with
accurate measurement, to depositing the pure
chemical on the skin surface. No irritation was ob-
served. No crystals were visible on the skin sur-
face at the concentration reported here. While
acetone is a lipid solvent, this method could not
remove bpid because it was evaporated on the
test site. Some redistribution of lipids within the
epidermis is possible, but should be minimal with
the brief application.
While the same chemical surface concentration
was always used, some compounds required method
modification to allow application of sufficient "C
for adequate analysis. We used minimal doses of
radioactivity. One pc was used, except 5 rc were
required for the pharmacologically active glueo-
eorticoids. The specific radioactivity of dexa-
methasone required the use of six standard circu-
lar areas on the forearm. Fluoeinolone aeetonide
had a specific activity requiring application to a
500 em' area of the back. On the other hand, the
specific activity of some compounds was so high
that non-radioactive carrier was added to obtain
the correct chemical surface concentration.
The skin sites were not protected. The subjects
were asked not to wash the area for 24 hours.
Originally we wished to measure penetration
under conditions of ordinary use. Our initial stud-
ies on hydroeortisone showed that occlusion of
the application site increased penetration ten-fold
(1). We attempted to apply non-occlusive skin
guards of various types, hut these were apt to
move around, particularly while the subject slept,
with the result that the area was continuously
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rubbed rather than protected. The best experi-
ment appeared to be subjecting the application
site to its ordinary environment. More reproduci-
ble results might be obtained using non-occlusive
protection.
Analysis. All urine was collected for five days
with the first day broken into two 12 hour periods.
The 24C content of 5 ml aliquots was measured by
a method described previously (1, 2). All carbon
in the urine was chemically oxidized to CO2; the
CO2 was absorbed in the organic base, ethanol-
amine, which was dissolved in a suitable phosphor,
and the radioactivity was measured in a liquid
scintillation counter. While this method of sample
preparation involves considerable effort, the sensi-
tivity and reproducibility were essential for the
less rapidly absorbed compounds. As better ab-
sorbed compounds were encountered, we elected to
lower the quantity of radioactivity rather than use
simpler analytical methods. At the end of the five
day period C measurements approached back-
ground levels. Compounds with slow absorption in
some eases gave low readings in the scintillation
counter. The larger statistical error is reflected in
the values obtained. Comparison with more rap-
idly absorbed compounds, however, is significant.
Results are calculated as percent of the applied
dose for each urine collection. Dividing this value
by the proportion recovered in urine after paren-
teral administration will give the total amount
absorbed through the skin during the time period
represented by that collection. Division by time
gives the absorption rate. Both rates and totals
are of interest and are included in the results.
Quantities of the test steroid are always ex-
pressed as percent of the dose applied. The amount
applied was always four micrograms for each
square centimeter of skin surface, so the figures
could have been converted to micrograms or micro-
moles per square centimeter. Percentage figures,
however, appear easier to interpret.
RESULTS
The data on "C recovery in the urine after
parenteral administration of the test steroid
are summarized in Table I.
All were excreted sufficiently rapidly to per-
mit accurate measurement of absorption
through the skin. The factor for conversion to
100% excretion is in the third column. Corti-
sone, eortieosterone, 17-OH desoxycorticoster-
one, desoxyeortieosterone, and 17-OH proges-
terone are in the same metabolic pool as
hydroeortisone, and it is assumed that they
are similarly excreted. For the same reason,
the values for testosterone were used for
sents the data on absorption rate graphically
for representative steroids. Figure 2 shows the
maximum rate observed for each steroid. The
total absorption vahies are compared in Fig-
ure 3.
Considerable variation in absorption was
noted. Cenerally the glucoeorticoids such as
hydrooortisoue, dexamethasone, and fluocino-
lone acotonide had the lowest degree of total
penetration (in the order of 1% of the applied
dose). The non-csterified androgens such as
testosterone, androstenedione and dehydro-
epiandrosterone were best absorbed (in excess
of 13% of the applied dose). Esterification ap-
peared to increase the penetration of hydro-
cortisone (although not statistically significant)
but decreased that of testosterone (P =
.05).
Because all four of the steroids with anti-
inflammatory activity showed the least ab-
sorption, and because they are also known to
produce vasooonstriction (not visible at con-
centrations used in this study) which might
slow absorption, it ivas decided to measure the
effect of topically applied hydrocortisone on
the absorption of another steroid. Unlabelled
hydroeortisone was applied at three times the
concentration used for measuring penetration.
The test steroid was "C labelled testosterone
and was concomitantly applied. These results
are in Table III. An increase rather than a
decrease in absorption was observed indicating
that hydrocortisone does not, itself, interfere
with absorption at concentrations used in this
study.
TABLE I
i4C recovery in urine after IV. administration
Steroid Half life% Recovered (hrs)
Factor to
corcect to
100%
1.53
1.45
1.94
1.09
1.46
2.70
65.4
68.9
51.6
92.1
68.7
37.0
47.4
5
5
8
4
4
5.5
4
testosterone acetate, testosterone propionatc,
dehydroepiandrosterone, and androstenediono.
The data obtained after topical adminis Era-
2.11 tion are summerized in Table II. Figure 1 pre-
DISCUSSION
These data represent the first examination
of the penetration characteristics of a series
of steroids with an in vivo, human assay.
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Steroid
TABLE IT
Absorption after topical administration
Absorption rate (%/hr)
Time (hrs)
0—12
12—24 24—48 48—72
Total Absorption
72—96 96—120 % of dose
No.
subjects
S.D.
Hydrocortisone
Hydrocortisone acetate
Cortisone
Corticosterone
17-OH DOC
Desoxycorticosterone
17-OH Progesterone
Progesterone
Fluocinolone acetonide
Dexamethasone
Estradiol
Testosterone
Testosterone acetate
Testosterone propionate
Dehydroepiandrosterone
Androstenedione
• 005
.020
.015
.013
.041
.197
.042
.208
.002
.005
.008
.147
.103
.061
.265
.183
.023
.089
.037
.065
.101
.313
.120
.264
.011
.003
.056
.364
.133
.096
.446
.334
.019
.032
.039
.139
.084
.143
.213
.135
.012
.004
.099
.156
.048
.035
.249
.155
.018
.024
.036
.070
.076
.069
.211
.045
.016
.003
.101
.066
.015
.015
.091
.076
.016
.015
.032
050
.062
.035
.078
.024
.008
.002
.107
.036
.007
.009
.046
.043
.010
.008
.024
.039
.055
.020
.031
.011
.005
.002
.103
.018
.004
.005
.028
.028
1.87
2.55
3.38
8.78
8.41
12.55
14.76
10.81
1.34
.40
10.62
13.24
4.62
3.44
18.45
13.47
1.59
1.80
1.64
5.35
4.28
8.53
11.35
5.78
1.05
.23
4.86
3.04
2.28
1.03
7.71
5.
15
6
7
6
5
6
7
6
9
3
3
17
6
9
6
11
.4
20
0
.1
There is a fifty-fold difference in the total surface areas. The chance for systemic effect
absorption between the least and the most ab- will be increased under conditions known to
sorbed, The difference in the maximum absorp- decrease the skin's barrier properties (occlu-
tion rate is nearly 100 fold. The values ob- sive dressings, dimethyl sulfoxide application,
tamed were such that systemic effects could and some disease states).
be anticipated for some hormones after appli- The values obtained are consistent with pre-
cation of this relatively small concentration vious clinical and experimental observations.
(equivalent to a 0.25% cream) to moderate Malkinson observed testosterone disappeared
from the skin surface much more rapidly than
hydrocortisone (5). Scoggins (6) and Goldman
(7) reported chemical evidence of systemic
effect of topically applied corticoids. Systemic
estrogen effects seem relatively common after
topical estrogen application (4).
An index for systemic effect of topically
applied hormones can be calculated from the
values for total absorption and the quantity
known to produce systemic effects. These
values are shown in Table IV. It is not sur-
prising that estradiol, being both potent and
well-absorbed has the highest index, while
hydrocortisone, rcquiring 50 times the dose and
having one-fifth the absorption, has a low
index. An unusual systemic hormonal effect
was reported to follow topical administration
of 9-alpha fluorohydrocortisone Livingood (8).
While the compound was being used topically
TIME IN HOURS as an anti-inflammatory corticoid, systemic
signs of sodium retention were clinically oh-
FIG. 1. Absorption rates of selected steroids for
5 days after application, served. Unfortunately, we cannot measure its
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ESTRADIOI
TESTOSTERONE
TESTOSTERONE ACETATE
TESTOSTERONE PROPIONATE
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AND RO STE N E DION E
Fic. 2. Maximum absorption rate observed for each steroid
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Fic. 3. Total absorption of each steroid
absorption because it is not available with a
'4C label. Even if it were absorbed, as is
hydroeortisone, the systemic effect might be
explained by its great potency for retaining
electrolytes, the effective systemic dose being
0.1 mg (1/200 that of hydrocortisone).
It is particularly important that we under-
stand the potential for skin penetration of the
anti-inflammatory corticoids. A considerable
number are in clinical use, in a large number of
patients, often for relatively minor conditions,
for long periods of time and on large body
areas. The nature of the systemic effects of
these compounds makes their avoidance de-
sirable. This is, in fact, the reason topical
corticoids are usually tried before systemic
corticoids are employed.
The therapeutic effectiveness of topically ap-
plied corticosteroids can be increased by oc-
clusive dressings or by the use of dimethyl
sulfoxide (4). Both increase the hormone's
penetration. Most diseases responsive to topical
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MAXIMUM ABSORPTION RATE (% of dose/hr)
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a
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corticoids are primarily inflammatory diseases
of the dermis. It is therefore probable that
penetration into the dermis must occur before
a corticoid can be effective. It is possible that
topical corticoid therapy can be substantially
improved if we can evaluate separately three
factors: 1) the degree of penetration; 2) an in-
dex for local therapeutic effect; and 3) an in-
dex for systemic toxicity.
Percutaneous penetration is generally con-
sidered to be by diffusion rather than active
transport. The in vitro studies of Blank (9)
and an in vivo study by Wurster (10) demon-
strate penetration's dependence on physical
laws. An important aspect of these laws is the
basic difference in the ease of penetration of
different compounds, which can be expressed
mathematically as a permeability constant.
The penetration rate of a given compound will
relate to the difference in effective concen-
trations between the surface and the dermis
and the permeability constant. Differences we
have observed must be related to this perme-
ability constant, as we have used the same
amount of material in each experiment.
Obviously many other factors would affect
the actual penetration rate under clinical cir-
cumstances. Anatomic skin differences skin
temperature, humidity and the presence of
disease arc important. A large factor would be
the rate at which the test substance is lost
externally. Without external loss, even slowly
absorbed compounds would show nearly total
absorption with enough time.
The values derived in this study for both
the total penetration and the maximum pene-
tration rate must represent some function of
the permeability constant. Our inability to
control the environmental factors will make
these values less reliable than physicochcmical
measurements using dead skin, or its com-
ponents, under strict environmental conditions.
However, in this in vivo experiment we need
not be concerned with possible alterations of
physical properties due to postmortem changes.
Data comparing the compounds under in vivo
and in vitro conditions would be valuable.
The ultimate goal in percutaneous penetra-
tion research is to bypass in vivo and in vitro
studies and determine the permeability con-
stant from physical properties. Stoughton
used the pharmacologic properties of nicotinic
TABLE III
Effect of topical hydrocortisone on absorption
of testosterone
Steroid
N
jecta
Total Stand-
devia-
tion
14C testosterone, 4gm/cm2
and hydrocortisonc, 12 zgm/
cm5
"C testosterone, 4 pgm/cm2
"C hydrocortisone, 4 ,zgm/cm2
3
17
15
30.4
13.2
1.9
10.4
3.0
1.6
TABLE IV
Index of systemic effect
Compound
Testosterone
Hydrocortisouc
Estradiol
Dexamcthasonc
Progesterone i
Topical Effertive
absorption systemic(% of dose) dose (mg)
13.2 10
1.87 25
10.6 .5
0.40 .75
10.8 20
Topical
absorption
index
1.33
.07
21.0
0.55
0.54
acid esters (11) to evaluate their percutaneous
penetration and related increased penetration
due to the oil-water partition coefficient. He
did the same in an in vitro study of organic
boron compounds (12). Blank (9) related in
vitro penetration of a series of alcohols to the
distribution constant between water and non-
polar liquids.
We are presently studying our findings in
relation to water solubility, oil solubility and
their distribution coefficient. There are two
obvious exceptions in this study to the oil-
water distribution coefficient theory. The
highest coefficients are for the two esters of
testosterone. If this theory apphed, their ab-
sorption should be greater than testosterone.
In both eases it was significantly less (P <
0.01).
There does appear to be some physical re-
lationship, however. The series of 21 carbon
steroids shows a stepwise increase in absorption
for each hydroxyl removed. The number of
hdroxyl groups is known to greatly affect oil
and water solubility. In two instances we have
pairs of compounds with the same number of
hydroxyl groups. Corticosterone and 17-OH
desoxycorticosterone each have two; dcsoxy-
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corticosterone and 17-OH progesterone each
have one. For each pair, the ahsorptions are
reasonably close. Blank has made a similar
observation on polyhydroxy alcohols (13).
We believe that permeability is related in
some way to the solubility in oil and water.
The relationship is probably more complex than
a simple numerical relationship to the partition
coefficient. Before any such relationship could
be stated as a general principle it would have
to be shown to apply to chemically unrelated
compounds.
SUMMARy
1. Percutaneous penetration of 16 4C la-
belled steroids has been measured in man. Ab-
sorption was measured by excretion of '4C in
urine.
2. Steroids studied include a number of
natural and synthetic adrenal cortical hormones,
estradiol, progesterone, and several androgens.
3. Active glucoeortieoids (natural and syn-
thetic) show the least absorption (about 1%)
while naturally occurring androgens show the
greatest (more than 13%). Progesterone,
estradiol and non-glueoeorticoid adrenal hor-
mones give intermediate results.
4. Esters appear to behave differently from
their parent steroid.
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